The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Computational Science, 2017Software for the Analysis of Data on Parkinson's Disease Symptoms Collected Using Wearable Technology
Study Rationale:
Smartphone apps and wearable technology with built-in sensors allow people with Parkinson's disease (PD) to track motor symptoms such as tremor. The nature of this technology allows... -
Research Grant, 2017Searching for the Cause of Parkinson’s Disease in People with GBA Mutations
Study Rationale:
The GBA gene is responsible for the production of beta-glucocerebrosidase, an enzyme that breaks down fats. Scientists are starting to recognize changes, or mutations, in the GBA gene... -
Computational Science, 2017Using "Big Data" Methods to Better Plan Clinical Trials and Predict Outcomes of Parkinson's Disease
Study Rationale:
Parkinson’s disease (PD) progresses differently in every case, which makes reliable prediction of future outcomes challenging. Looking for better ways to predict disease progression... -
LRRK2 Therapeutic and Safety Initiative, 2017Using Organs-on-Chips to Test the Safety of New Drugs for Parkinson's Disease
Study Rationale:
Organs-on-Chips is a technology that recreates human biology in a microscopic device. In simple terms, the device comprises cells from a human organ, such as the lungs, attached to a... -
LRRK2 Therapeutic and Safety Initiative, 2017Genetic and Clinical Basis for Inflammatory Bowel Disease and Parkinson's Disease Comorbidity
Study Rationale:
Recent studies have shown that mutations in the LRRK2 gene, known to increase the risk of Parkinson’s disease (PD), are also associated with inflammatory bowel disease (IBD), a... -
LRRK2 Biology Consortium, 2017LRRK2 Activity and Dyskinesia
Promising Outcomes of Original Grant:
Leucine-rich repeat kinase 2 (LRRK2) is the greatest known genetic contributor to Parkinson's disease (PD). We previously studied the role of LRRK2 in the...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.